Interleukin-7 in T-cell acute lymphoblastic leukemia: an extrinsic factor supporting leukemogenesis?
about
Notch signaling: its roles and therapeutic potential in hematological malignanciesRedox regulation of T-cell function: from molecular mechanisms to significance in human health and diseaseThe relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemiaMechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer ImmunotherapyRelB-dependent stromal cells promote T-cell leukemogenesisGene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.Interleukin-7 mediates glucose utilization in lymphocytes through transcriptional regulation of the hexokinase II geneNotch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies.Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responsesHigh-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling.The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways.Defined, serum-free conditions for in vitro culture of primary human T-ALL blasts.Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.Interlinking interleukin-7.Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications.Genotoxicity of retroviral hematopoietic stem cell gene therapy.Opposing functions of IL-2 and IL-7 in the regulation of immune responses.Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises.RasGRP Ras guanine nucleotide exchange factors in cancer.JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.Synergistic effects of interleukin-7 and pre-T cell receptor signaling in human T cell development.Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesisThe proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.Signaling thresholds govern heterogeneity in IL-7-receptor-mediated responses of naïve CD8(+) T cells.Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells.DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells
P2860
Q26765033-64880125-BCF9-49EF-B043-30F1CF5E2778Q26824042-A4BBEBD8-5467-4415-B062-CF4C04F09F7DQ28075211-F59FD6A6-7E5B-45E1-82AB-BE5747DF19E1Q28084138-32F43CD6-A222-449F-9546-FDABD0B138E3Q33348553-AB1252DA-4EC4-4511-BCE7-07CD91F592FFQ33888105-8D19FCCF-9A42-4ABF-BCDF-42033A5362B5Q33929770-F2F78A60-1EC0-4B59-86A5-657545DE71FAQ34376282-232BE6D1-F20E-44C4-A3D1-721E2E3E82B8Q34633434-8A0CF43F-3E20-4D5E-9010-45FE6C4F3203Q35208383-C2927248-4CBF-4828-9DB7-BCA5AC807222Q35856790-A7942A3F-1F75-47BE-A58C-D985792E717DQ36440699-48F2F064-EFFD-458C-B746-2126688DF2F9Q36812729-C342B646-E2FA-4C06-8940-13220FB7F70EQ36927826-E2E63367-A46B-4EC6-BB05-FD1A75ABD6C6Q37167254-039224CB-5986-441E-B887-804DA81F73DDQ37849774-5E8D6F81-E48F-43EA-AE11-001B33344DC1Q37909733-D55EF932-9BC4-4AA3-84D5-CE47F1423AA3Q37934968-B2900E8A-20E0-4AA6-B0C7-96DBC4D870ADQ38205441-8D8AEC21-2498-4408-867F-52A4FC5648DFQ38796883-CAFBC0EE-50A0-41A0-A055-656E2B5DA50FQ39303166-55040DF1-5364-497B-9365-FE2A20AB012DQ39444659-83BAB05E-37D3-443B-9FB7-04C7B52C48F3Q39873607-9F395D3A-F3D0-4FB1-981E-084E77445810Q42144887-524C4758-90B6-45B6-B6E2-EE7DE2AAB250Q43599325-6765DEAC-5215-4214-9D7F-88ACB0FDB004Q54186977-4E616FE3-8236-4DAE-B556-86AB6DD0348FQ58762852-E179B428-32F9-4E7D-B6AF-2F10ED5E0F54
P2860
Interleukin-7 in T-cell acute lymphoblastic leukemia: an extrinsic factor supporting leukemogenesis?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Interleukin-7 in T-cell acute ...... tor supporting leukemogenesis?
@ast
Interleukin-7 in T-cell acute ...... tor supporting leukemogenesis?
@en
type
label
Interleukin-7 in T-cell acute ...... tor supporting leukemogenesis?
@ast
Interleukin-7 in T-cell acute ...... tor supporting leukemogenesis?
@en
prefLabel
Interleukin-7 in T-cell acute ...... tor supporting leukemogenesis?
@ast
Interleukin-7 in T-cell acute ...... tor supporting leukemogenesis?
@en
P2860
P1433
P1476
Interleukin-7 in T-cell acute ...... tor supporting leukemogenesis?
@en
P2093
Angelo A Cardoso
Vassiliki A Boussiotis
P2860
P304
P356
10.1080/10428190400027852
P577
2005-04-01T00:00:00Z